Listing & Compliance Notices

RenX Enterprises Corp. received a nasdaq compliance regained notice regarding stockholders equity (rules 5550(b)(1)).

“February 14, 2025, Safe and Green Development Corporation (the “Company”) received a letter from The Nasdaq Stock Market (“Nasdaq”) stating that based on the Company’s Form 8-K, as filed with the Securities and Exchange”

Sotherly Hotels Inc. received a nasdaq deficiency notice notice regarding minimum bid price (rules 5450(a)(1)).

“February 11, 2025, Sotherly Hotels Inc. (the “Company”) received a deficiency letter (the “Notice”) from The Nasdaq Stock Market LLC (“Nasdaq”), notifying the Company that, for the last 30 consecutive business days, the closing bid price for the Company’s common stock has been below the minimum $1.00 bid price per share requirement for continued listing on The Nasdaq Global Market pursuant to Listing Rule 5450(a)(1) (the “Minimum Bid Price Requirement”). The Notice has no immediate effect on the listing of the Company’s common stock, and its common stock will continue to trade on The Nasdaq Gl”

Dare Bioscience, Inc. received a nasdaq delisting notice notice regarding market value (rules 5550(b)(2)).

“February 13, 2025, Nasdaq’s Listing Qualifications Department (the “Staff”) notified the Company that because the Company did not timely regain compliance with the Minimum MVLS Rule by February 10, 2025, the Company’s common stock is subject to delisting from Nasdaq unless the Company timely requests a hearing before the Nasdaq Hearing Panel (the “Panel”). The Company will timely request a hearing before the Panel, which request will stay the delisting of the Company’s common stock pending the Panel’s decision following the hearing and the expiration of any extension period that the Panel may”

Iterum Therapeutics plc received a nasdaq noncompliance notice notice regarding audit committee (rules 5605(c)(2)(A)).

“February 14, 2025, Iterum Therapeutics plc (the “Company”), notified the Nasdaq Stock Market LLC (“Nasdaq”) that the Company will not be in compliance with the audit committee requirement under Nasdaq Listing Rule 5605(c)(2)(A) as of February 14, 2025, solely due to a vacancy on the audit committee (the “Audit Committee”) of the Company’s Board of Directors (the “Board”) resulting from Ronald Hunt’s resignation from the Board as disclosed in”

byNordic Acquisition Corp received a nasdaq delisting notice notice regarding other (rules IM-5101-2, 5815(c)(1)(H), 5800).

“isting and registration on Nasdaq pursuant to Nasdaq Listing Rule IM-5101-2 (“ Rule IM-5101-2 ”). Under Rule IM-5101-2, a special purpose acquisition company must complete one or more business combinations within 36 months of the effectiveness of its initial”

Bolt Projects Holdings, Inc. received a nasdaq deficiency notice notice regarding market value (rules 5450(b)(2)(C)).

“February 10, 2025, Bolt Projects Holdings, Inc. (the “Company”) received a letter from the Listing Qualifications Department of The Nasdaq Stock Market LLC (“Nasdaq”) notifying the Company that, for the last 30 consecutive business days, the Minimum Value of Listed Securities, as defined by Nasdaq (“MVLS”), of the Company’s common stock, par value $0.0001 per share (the “Common Stock”), has been below the minimum $50 million requirement for continued listing on The Nasdaq Global Market under Nasdaq Listing Rule 5450(b)(2)(A) (the “Minimum Market Value of Listed Securities Requirement”). On the”

Bolt Projects Holdings, Inc. received a nasdaq deficiency notice notice regarding market value (rules 5450(b)(2)(A)).

“February 10, 2025, Bolt Projects Holdings, Inc. (the “Company”) received a letter from the Listing Qualifications Department of The Nasdaq Stock Market LLC (“Nasdaq”) notifying the Company that, for the last 30 consecutive business days, the Minimum Value of Listed Securities, as defined by Nasdaq (“MVLS”), of the Company’s common stock, par value $0.0001 per share (the “Common Stock”), has been below the minimum $50 million requirement for continued listing on The Nasdaq Global Market under Nasdaq Listing Rule 5450(b)(2)(A) (the “Minimum Market Value of Listed Securities Requirement”). On the”

Agriculture & Natural Solutions Acquisition Corp received a nasdaq deficiency notice notice regarding other (rules 5620(a), 5810(c)(2)(G)).

“February 11, 2025, Agriculture & Natural Solutions Acquisition Corporation (the "Company") received a notification letter from the Listing Qualifications Staff (the "Staff") of The NASDAQ Stock Market LLC ("Nasdaq") indicating that, since the Company has not held an annual meeting of shareholders within twelve months of the end of the Company's fiscal year ended December 31, 2023, it is out of compliance with the Nasdaq rules for continued listing (Listing Rules 5620(a) and 5810(c)(2)(G)). The notification letter has no immediate effect on the listing of the Company’s securities on the Nasdaq.”

DevvStream Corp. received a nasdaq deficiency notice notice regarding minimum bid price (rules 5550(a)(2)).

“February 12, 2025, DevvStream Corp. (the “Company”) received notice (the “Notice”) from the Listing Qualifications staff of The Nasdaq Stock Market LLC (“Nasdaq”) that, because the closing bid price for the Company’s common stock had fallen below $1.00 per share for 30 consecutive trading days, the Company no longer complies with the minimum bid price requirement for continued listing on the Nasdaq Capital Market under Nasdaq Listing Rule 5550(a)(2) because the closing bid price of the Company’s common stock for the prior 30 consecutive business days was lower than the minimum bid price requ”

Aspira Women's Health Inc. received a nasdaq deficiency notice notice regarding other (rules 5635(c)).

“February 11, 2025, the Company received written notice (the “Notice”) from the Nasdaq Stock Market, LLC (“Nasdaq”) that based on the closing bid price per share immediately preceding entering into a binding agreement to issue the securities for the Private Placement of $1.47 per share plus $0.125 attributable to the value of the warrants, the market value of the transaction for purposes of Listing Rule 5625(c) was $1.595. Since the shares and warrants sold in the private placement were issued below the market value, and the Company failed to obtain shareholder approval, the Company violated Li”

Aspira Women's Health Inc. received a nasdaq deficiency notice notice regarding shareholders (rules 5635(c)).

“February 11, 2025, the Company received written notice (the “Notice”) from the Nasdaq Stock Market, LLC (“Nasdaq”) that based on the closing bid price per share immediately preceding entering into a binding agreement to”

Global Star Acquisition Inc. received a nasdaq delisting notice notice.

“January 31, 2025, the Company received a delist determination letter from Nasdaq advising the Company that Nasdaq had determined that the Company did not meet the terms of the extension. On February 7, 2025, the Company”

Agriculture & Natural Solutions Acquisition Corp received a nasdaq deficiency notice notice regarding other (rules 5620(a), 5810(c)(2)(G)).

“February 11, 2025, Agriculture & Natural Solutions Acquisition Corporation (the "Company") received a notification letter from the Listing Qualifications Staff (the "Staff") of The NASDAQ Stock Market LLC ("Nasdaq") indi”

DevvStream Corp. received a nasdaq deficiency notice notice regarding minimum bid price (rules 5550(a)(2)).

“February 12, 2025, DevvStream Corp. (the “Company”) received notice (the “Notice”) from the Listing Qualifications staff of The Nasdaq Stock Market LLC (“Nasdaq”) that, because the closing bid price for the Company’s co”

Bolt Projects Holdings, Inc. received a nasdaq deficiency notice notice regarding market value (rules 5450(b)(2)(C)).

“February 10, 2025, Bolt Projects Holdings, Inc. (the “Company”) received a letter from the Listing Qualifications Department of The Nasdaq Stock Market LLC (“Nasdaq”) notifying the Company that, for the last 30 consecuti”

Bolt Projects Holdings, Inc. received a nasdaq deficiency notice notice regarding market value (rules 5450(b)(2)(A)).

“February 10, 2025, Bolt Projects Holdings, Inc. (the “Company”) received a letter from the Listing Qualifications Department of The Nasdaq Stock Market LLC (“Nasdaq”) notifying the Company that, for the last 30 consecuti”

byNordic Acquisition Corp received a nasdaq delisting notice notice regarding other (rules IM-5101-2).

“February 11, 2025, byNordic Acquisition Corporation, a Delaware corporation (the “ Company ”, “ BYNO ”), received a letter from the Listing Qualifications Department of The Nasdaq Stock Market (“ Nasdaq ”) stating that t”

Iterum Therapeutics plc received a nasdaq deficiency notice notice regarding audit committee (rules 5605(c)(2)(A)).

“February 14, 2025, Iterum Therapeutics plc (the “Company”), notified the Nasdaq Stock Market LLC (“Nasdaq”) that the Company will not be in compliance with the audit committee requirement under Nasdaq Listing Rule 5605(c”

Dare Bioscience, Inc. received a nasdaq delisting notice notice regarding market value (rules 5550(b)(2)).

“February 13, 2025, Nasdaq’s Listing Qualifications Department (the “Staff”) notified the Company that because the Company did not timely regain compliance with the Minimum MVLS Rule by February 10, 2025, the Company’s co”

Sotherly Hotels Inc. received a nasdaq deficiency notice notice regarding minimum bid price (rules 5450(a)(1)).

“February 11, 2025, Sotherly Hotels Inc. (the “Company”) received a deficiency letter (the “Notice”) from The Nasdaq Stock Market LLC (“Nasdaq”), notifying the Company that, for the last 30 consecutive business days, the”

Clearside Biomedical, Inc. received a nasdaq deficiency notice notice regarding minimum bid price (rules 5450(a)(1), 5810(c)(3)(A)).

“February 7, 2025, Clearside Biomedical, Inc. (the “ Company ”) received a notice from the Listing Qualifications Department of The Nasdaq Stock Market LLC (“ Nasdaq ”) notifying the Company that the listing of its common stock was not in compliance with Nasdaq Listing Rule 5450(a)(1) for continued listing on the Nasdaq Global Market, as the minimum bid price of the Company’s common stock was less than $1.00 per share for the previous 30 consecutive business days. The notice has no present impact on the listing of the Company’s securities on the Nasdaq Global Market. Under Nasdaq Listing Rule 5”

Ovid Therapeutics Inc. received a nasdaq deficiency notice notice regarding minimum bid price (rules 5450(a)(1)).

“February 10, 2025, Ovid Therapeutics Inc. (the “Company”) received a notification letter from the Nasdaq Listing Qualifications Department of The Nasdaq Stock Market LLC (“Nasdaq”) notifying the Company that the average closing bid price of the Company’s shares of common stock was below the minimum closing bid price of $1.00 per share during the last 31 consecutive trading days (the “Notice”), as required for continued listing on the Nasdaq under Rule 5450(a)(1) of the Nasdaq’s Listing Rules (the “Rules”). The Notice has no immediate impact on the listing of the Company’s common stock, which w”

Banzai International, Inc. received a nasdaq compliance regained notice regarding other (rules 5550(a)(2), 5550(a)(5), 5550(b)(1)).

“February 12, 2025, the Company received a letter from the Nasdaq Stock Market LLC, Office of the General Counsel that Nasdaq’s Listing Qualifications staff confirmed that the Company has demonstrated compliance with all of The Nasdaq Stock Market’s listing requirements and therefore the Company’s securities will remain listed on the Exchange.”

Royalty Management Holding Corp received a nasdaq extension granted notice regarding other (rules 5620(a)).

“February 12, 2025, Nasdaq provided the Company with written notification that its staff has determined to grant the Company an extension until June 30, 2025 to regain compliance with Listing Rule 5620(a) pursuant to the Company’s proposed plan by, among other conditions, holding an annual meeting of shareholders. The Company fully anticipates complying with the requirements of the Nasdaq under this letter within the time period specified.”

Zoomcar Holdings, Inc. received a nasdaq extension granted notice regarding stockholders equity (rules 5550(b)(1)).

“February 10, 2025, the Company received a letter from the Panel (the “ Panel Decision Letter ”) stating that, based on the information presented, the Panel has determined to grant the Company’s request for continued listing on Nasdaq, subject to the Company satisfying certain conditions, including transferring its listing to The Nasdaq Capital Market and demonstrating compliance with Nasdaq Listing Rule 5550(b)(1), which requires a stockholders' equity of at least $2.5 million for continued listing on The Nasdaq Capital Market (the “ Equity Rule ”), on or before March 31, 2025. The Company is”

FutureTech II Acquisition Corp. received a nasdaq compliance regained notice.

“February 12, 2025, FutureTech II Acquisition Corp (the “Company”) received a letter (the “Determination Letter”) from The Nasdaq Stock Market LLC (“Nasdaq”) stating that the Company had regained compliance with the listing rules and the matter is now closed. As previously disclosed in the Current Reports on Form 8-K filed with the Securities and Exchange Commission on November 27, 2024, December 4, 2024 and January 15, 2025, the Company previously received deficiency notifications from the staff of Nasdaq for failure to comply with certain Nasdaq Listing Rules as described in these Current Rep”

FutureTech II Acquisition Corp. received a nasdaq compliance regained notice.

“February 12, 2025, FutureTech II Acquisition Corp (the “Company”) received a letter (the “Determination Letter”) from The Nasdaq Stock Market LLC (“Nasdaq”) stating that the Company had regained compliance with the listi”

Zoomcar Holdings, Inc. received a nasdaq extension granted notice regarding stockholders equity (rules 5550(b)(1)).

“February 10, 2025, the Company received a letter from the Panel (the “ Panel Decision Letter ”) stating that, based on the information presented, the Panel has determined to grant the Company’s request for continued list”

Zoomcar Holdings, Inc. received a nasdaq deficiency notice notice regarding market value (rules 5450(b)(2)(C)).

“January 23, 2025, the Company received a further notice from the Staff, notifying the Company that its failure to maintain compliance with the market value of publicly held shares requirement for continued listing on The”

Royalty Management Holding Corp received a nasdaq extension granted notice regarding shareholders (rules 5620(a)).

“February 12, 2025, Nasdaq provided the Company with written notification that its staff has determined to grant the Company an extension until June 30, 2025 to regain compliance with Listing Rule 5620(a) pursuant to the”

Royalty Management Holding Corp received a nasdaq deficiency notice notice regarding shareholders (rules 5620(a)).

“January 29, 2025, Royalty Management Holding Corporation (or the “Company”) disclosed that the Company had received a letter from Nasdaq Regulation (“Nasdaq”) indicating that the Company has not yet held an annual meetin”

Banzai International, Inc. received a nasdaq compliance regained notice regarding other (rules 5550(a)(2), 5550(a)(5), 5550(b)(1)).

“February 12, 2025, the Company received a letter from the Nasdaq Stock Market LLC, Office of the General Counsel that Nasdaq’s Listing Qualifications staff confirmed that the Company has demonstrated compliance with all”

Ovid Therapeutics Inc. received a nasdaq deficiency notice notice regarding minimum bid price (rules 5450(a)(1)).

“February 10, 2025, Ovid Therapeutics Inc. (the “Company”) received a notification letter from the Nasdaq Listing Qualifications Department of The Nasdaq Stock Market LLC (“Nasdaq”) notifying the Company that the average”

Clearside Biomedical, Inc. received a nasdaq deficiency notice notice regarding minimum bid price (rules 5450(a)(1)).

“February 7, 2025, Clearside Biomedical, Inc. (the “ Company ”) received a notice from the Listing Qualifications Department of The Nasdaq Stock Market LLC (“ Nasdaq ”) notifying the Company that the listing of its common”

URBAN ONE, INC. received a nasdaq deficiency notice notice regarding minimum bid price (rules 5550(a)(2), 5810(c)(3)(A)).

“February 11, 2025, Urban One Inc. (the “Company”) received written notice (the “Notice”) from the Listing Qualifications Department of The Nasdaq Stock Market LLC (“Nasdaq”) notifying the Company that, for the last 30 consecutive business days, the bid price for the Company’s Class D common stock, par value $0.001 per share (the “Class D Common Stock”) had closed below the $1.00 per share minimum bid price requirement for continued inclusion on the Nasdaq Capital Market pursuant to Nasdaq Listing Rule 5550(a)(2) (the “Minimum Bid Price Requirement”). The Notice has no immediate effect on the l”

Big Digital Energy, Inc. received a nasdaq deficiency notice notice regarding minimum bid price (rules 5810(c)(3)(H)).

“gain compliance with the Bid Price Rule, the bid price for the Company’s common stock must meet or exceed $1.00 per share minimum of ten consecutive business days during the Compliance Period (unless the Staff exercises its discretion to extend such ten business day period under Nasdaq Listing Rule 5810(c)(3)(H)). If the Company does not regain compliance by August 5, 2025, the Company may be eligible for an additional 180-day period to regain compliance. To qualify, the Company will be required to meet the continued listing requirement for market value of publicly held shares and all other in”

Staffing 360 Solutions, Inc. received a nasdaq delisting notice notice regarding stockholders equity (rules 5550(b)(1)).

“s Department of the Nasdaq Stock Market (the “ Staff ”) indicating that it was no longer in compliance with the minimum stockholders’ equity requirement (the “ Minimum Stockholders’ Equity Requirement ”) for continued listing on the Nasdaq Capital Market (“ Nasdaq ”) pursuant to Nasdaq Listing Rule 5550(b)(1), which such rule requires listed companies to maintain stockholders’ equity of at least $2,500,000 or meet the alternative compliance standards relating to the market value of listed securities or net income from continuing operations, which the Company does not currently meet. On August”

Genprex, Inc. received a nasdaq deficiency notice notice regarding minimum bid price (rules 5550(a)(2), 5810(c)(3)(A)).

“February 7, 2025, Genprex, Inc. (the “Company”) received a letter from the Listing Qualifications Department (the “Staff”) of The Nasdaq Stock Market (“Nasdaq”) notifying the Company that, based upon the closing bid price of the Company’s common stock, par value $0.001 per share (“Common Stock”), for the last 30 consecutive business days, the Company is not currently in compliance with the requirement to maintain a minimum bid price of $1.00 per share for continued listing on The Nasdaq Capital Market as set forth in Nasdaq Listing Rule 5550(a)(2) (the “Minimum Bid Price Requirement”). The Nas”

Alternus Clean Energy, Inc. received a nasdaq delisting notice notice regarding market value (rules 5550(b)(2), 5550(a)(2)).

“February 10, 2025, the Company received a determination letter (the “Delisting Notification”) from the Nasdaq Hearings Advisor stating that the Panel has determined to delist the Company’s common stock, par value $0.0001 per share (the “Common Stock”) from the Nasdaq Capital Market, and Nasdaq will accordingly suspend trading in the Company’s Common Stock, effective at the opening of trading on February 12, 2025, because the Company has not demonstrated compliance with the MVLS Rule, nor does it meet any of the alternative requirements under Nasdaq Listing Rule 5550(b) and has failed to demons”

MGO Global Inc. received a nasdaq deficiency notice notice regarding minimum bid price (rules 5550(a)(2), 5810(c)(3)(A)(iv)).

“February 6, 2025, MGO Global Inc., a Delaware corporation (the “ Company ”), received a written notice (the “ Notice ”) from The Nasdaq Stock Market LLC (“ Nasdaq ”) notifying the Company that it is not in compliance with the minimum bid price requirement set forth in Nasdaq Listing Rule 5550(a)(2) due to the Company’s common stock not maintaining a closing bid price of at least $1.00 per share for a period of 30 consecutive business days. The Notice has no immediate effect on the listing of the Company’s common stock on The Nasdaq Capital Market. The Company effected a reverse stock split on”

RenX Enterprises Corp. received a nasdaq extension granted notice regarding stockholders equity (rules 5550(b)(1)).

“January 22, 2025, the Company received written notification from Nasdaq granting the Company’s request for an extension through February 24, 2025 to evidence compliance with the Rule. The terms of the extension are as follows: on or before February 24, 2025, the Company must complete a significant portion of its Initiatives and may evidence compliance with the Rule by furnishing to the SEC and Nasdaq a publicly available report including: 1. A disclosure of Staff’s deficiency letter and the specific deficiency(ies) cited; 2. A description of the completed transaction or event that enabled the”

RenX Enterprises Corp. received a nasdaq extension granted notice regarding stockholders equity (rules 5550(b)(1)).

“January 22, 2025, the Company received written notification from Nasdaq granting the Company’s request for an extension through February 24, 2025 to evidence compliance with the Rule. The terms of the extension are as fo”

MGO Global Inc. received a nasdaq deficiency notice notice regarding minimum bid price (rules 5550(a)(2)).

“February 6, 2025, MGO Global Inc., a Delaware corporation (the “ Company ”), received a written notice (the “ Notice ”) from The Nasdaq Stock Market LLC (“ Nasdaq ”) notifying the Company that it is not in compliance wit”

Alternus Clean Energy, Inc. received a nasdaq delisting notice notice regarding market value (rules 5550(b)(2), 5550(a)(2)).

“February 10, 2025, the Company received a determination letter (the “Delisting Notification”) from the Nasdaq Hearings Advisor stating that the Panel has determined to delist the Company’s common stock, par value $0.0001”

Genprex, Inc. received a nasdaq deficiency notice notice regarding minimum bid price (rules 5550(a)(2)).

“February 7, 2025, Genprex, Inc. (the “Company”) received a letter from the Listing Qualifications Department (the “Staff”) of The Nasdaq Stock Market (“Nasdaq”) notifying the Company that, based upon the closing bid pric”

Staffing 360 Solutions, Inc. received a nasdaq delisting notice notice regarding stockholders equity (rules 5550(b)(1)).

“February 11, 2025, Staffing 360 Solutions, Inc. (the “ Company ”) received a letter (the “ Decision Letter ”) from the Nasdaq Stock Market LLC, stating that as the Company was unable to comply with the terms of the Octob”

Big Digital Energy, Inc. received a nasdaq deficiency notice notice regarding minimum bid price (rules 5550(a)(2), 5810(c)(3)(A)).

“February 6, 2025, Mawson Infrastructure Group Inc. (the “Company”) received written notice (the “Bid Price Notice”) from the Listing Qualifications Department (the “Staff”) of The Nasdaq Stock Market LLC (“Nasdaq”) notif”

URBAN ONE, INC. received a nasdaq deficiency notice notice regarding minimum bid price (rules 5550(a)(2), 5810(c)(3)(A)).

“February 11, 2025, Urban One Inc. (the “Company”) received written notice (the “Notice”) from the Listing Qualifications Department of The Nasdaq Stock Market LLC (“Nasdaq”) notifying the Company that, for the last 30 co”

T2 Biosystems, Inc. received a nasdaq delisting notice notice regarding minimum bid price (rules 5550(a)(2), 5550(b)(2)).

“February 10, 2025, the Nasdaq Stock Market LLC (“Nasdaq”) notified T2 Biosystems, Inc. (the “Company”) that the Nasdaq Hearings Panel (the “Panel”) has determined to delist the Company’s common stock and that trading of the Company’s common stock will be suspended at the open of trading on February 12, 2025. As previously reported, the Company was in violation of the bid price requirement of Nasdaq Listing Rule 5550(a)(2) (the “Bid Price Rule”) and the market value of listed securities requirement in Listing Rule 5550(b)(2) (the “MVLS Rule”). In accordance with the terms of the previously impo”

AMERICAN REBEL HOLDINGS INC received a nasdaq compliance regained notice regarding late filing.

“February 10, 2025, the Company received a written notification from the Staff indicating that the Company had regained compliance with the periodic filing requirement under Nasdaq Listing Rules.”